LHX3 is an advanced-stage prognostic biomarker and metastatic oncogene in hepatocellular carcinoma.

CONCLUSION: LHX3 is an advanced-stage prognostic biomarker, and acts as a new potential metastatic oncogene in HCC. PMID: 31306102 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/31306102?dopt=Abstract

Source: Cancer Biomarkers - July 16, 2019 Category: Cancer & Oncology Tags: Cancer Biomark Source Type: research